Skip to content

ChirDigest: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ChirDigest

BE 1011.887.667
NACE 86.220, Specialist medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€31,326
2024 · €34,908-€3,583
Equity
€70,234
2024 · €38,908+€31,326
Cash
-
not filed
Balance sheet total
€95,122
2024 · €54,896+€40,226

Largest movements

2024 to 2025
Assets
  • Current investments +€49,862

    up €49,862 (+143.8%), from €34,665 to €84,527

  • Receivables within one year -€7,439

    down €7,439 (-41.2%), from €18,034 to €10,595

    of which Trade receivables: -€7,439

  • Deferred charges and accrued income -€1,437

    no longer reported in 2025 (was €1,437)

Equity and liabilities
  • Profit (loss) carried forward +€31,326

    up €31,326 (+89.7%), from €34,908 to €66,234

  • Tax, wage and social debts +€10,283

    up €10,283 (+73.2%), from €14,054 to €24,337

    of which Taxes: +€9,124

  • Trade debts -€1,794

    down €1,794 (-92.8%), from €1,934 to €140

Income statement
  • Taxes +€9,178

    up €9,178 (+100.0%), from €9,181 to €18,359

  • Gross operating margin +€5,799

    up €5,799 (+13.0%), from €44,705 to €50,504

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €34,908
Gross operating margin +€5,799
Depreciation -€170
Financial income +€0
Financial charges -€34
Taxes -€9,178
Result 2025 €31,326

Cash bridge derived

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €54,896 €95,122 +€40,226 +73.3%
Formation expenses 20 €760 €0 -€760 -100.0%
Current assets 29/58 €54,136 €95,122 +€40,986 +75.7%
Amounts receivable within one year 40/41 €18,034 €10,595 -€7,439 -41.2%
Trade receivables 40 €17,963 €10,524 -€7,439 -41.4%
Other amounts receivable 41 €71 €71 = 0.0%
Current investments 50/53 €34,665 €84,527 +€49,862 +143.8%
Deferred charges and accrued income 490/1 €1,437 - -€1,437
Total equity and liabilities 10/49 €54,896 €95,122 +€40,226 +73.3%
Equity 10/15 €38,908 €70,234 +€31,326 +80.5%
Contributions 10/11 €4,000 €4,000 = 0.0%
Profit (loss) carried forward 14 €34,908 €66,234 +€31,326 +89.7%
Amounts payable 17/49 €15,988 €24,888 +€8,900 +55.7%
Amounts payable within one year 42/48 €15,988 €24,477 +€8,489 +53.1%
Trade debts 44 €1,934 €140 -€1,794 -92.8%
Suppliers 440/4 €1,934 €140 -€1,794 -92.8%
Taxes, remuneration and social security 45 €14,054 €24,337 +€10,283 +73.2%
Taxes 450/3 €11,938 €21,062 +€9,124 +76.4%
Remuneration and social security 454/9 €2,116 €3,274 +€1,159 +54.8%
Accrued charges and deferred income 492/3 - €411 +€411
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €590 €760 +€170 +28.8%
Gross operating margin 9900 €44,705 €50,504 +€5,799 +13.0%
Operating profit (loss) 9901 €44,115 €49,744 +€5,629 +12.8%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €26 €60 +€34 +131.7%
Recurring financial charges 65 €26 €60 +€34 +131.7%
Profit (loss) for the period before taxes 9903 €44,089 €49,684 +€5,596 +12.7%
Income taxes 67/77 €9,181 €18,359 +€9,178 +100.0%
Profit (loss) for the period 9904 €34,908 €31,326 -€3,583 -10.3%
Profit (loss) for the period to be appropriated 9905 €34,908 €31,326 -€3,583 -10.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.